NCCN Imaging Appropriate Use Criteria to be Integrated into MedCurrent’s OrderWise Platform
Integration of NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™) into MedCurrent’s OrderWise™ platform will provide access to evidence-based imaging recommendations adapted from the NCCN Guidelines®.
FORT WASHINGTON, PA — The National Comprehensive Cancer Network® (NCCN®) is collaborating with MedCurrent to integrate the NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™) into its clinical decision support (CDS) platform, OrderWise™, to allow for access to imaging recommendations as derived from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®).
“Integration of NCCN Imaging AUC directly into the electronic health care workflow through OrderWise™ will benefit providers with point-of-care access to qualified, NCCN Guidelines-based imaging recommendations to assure quality care of patients with cancer,” said Robert W. Carlson, MD, Chief Executive Officer, NCCN. “We welcome MedCurrent as an NCCN Health Information Technology (HIT) licensee and the opportunity to promote the standard of care set forth by expert NCCN Guidelines panels.”
Adapted from the NCCN Guidelines®, NCCN Imaging AUC™ support clinical decision-making around the use of imaging in patients with cancer by outlining all imaging procedures recommended in the NCCN Guidelines, including radiographs, computed tomography (CT) scans, magnetic resonance imaging (MRI), functional nuclear medicine imaging (PET, SPECT), and ultrasound. NCCN is recognized by Centers for Medicare & Medicaid Services (CMS) as an approved provider-led entity (PLE) for development of imaging AUC.
"MedCurrent’s continued collaboration with NCCN will enable more appropriate, evidence-based care for patients with cancer," said Stephen Herman, MD, Chief Medical Officer, MedCurrent Corporation. "Our team has been working closely with NCCN to integrate their Imaging AUC into MedCurrent’s CDS technology solution, with a focus on workflow and structuring clinical content that ensures the integrity and high-standards expected of NCCN. Our relationship with NCCN means leading oncology centers will now have access to nationally recognized recommendations delivered at the point of care by OrderWise.”
MedCurrent is a physician-founded CDS solutions provider focused on three core operating principles: improved quality of care, improved patient outcomes, and lower system health care costs. MedCurrent’s OrderWise™ solution is easy-to-use and highly configurable, supporting evidence-based care at the point of ordering. The OrderWise™ platform allows AUC from any approved platform to be incorporated to inform best practice, including qualified PLEs, such as NCCN.
NCCN Imaging AUC™ are currently available for 12 NCCN Guidelines; the complete library of NCCN Imaging AUC™ will be available beginning Q2 2017. NCCN Imaging AUC™ are expected to be integrated into OrderWise in parallel and available immediately thereafter.
More information about NCCN Imaging AUC™ is available at NCCN.org/ImagingAUC.
MedCurrent is a physician-founded Clinical Decision Support (CDS) solutions provider focused on three core operating principles: improved quality of care, improved patient outcomes, and lower system healthcare costs. Centered on a deep EMR integration philosophy, our technology platform streamlines provider ordering by merging evidence-based guidelines with clinical workflows at the point of care. Ease-of-use, configurability, and enterprise scalability make MedCurrent a global leader in CDS solutions. More information about MedCurrent is available at www.medcurrent.com.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 of the world’s leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.
The NCCN Member Institutions are: Fred & Pamela Buffett Cancer Center, Omaha, NE; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, FL, and Rochester, MN; Memorial Sloan Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UC San Diego Moores Cancer Center, La Jolla, CA; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Colorado Cancer Center, Aurora, CO; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; The University of Texas MD Anderson Cancer Center, Houston, TX; University of Wisconsin Carbone Cancer Center, Madison, WI; Vanderbilt-Ingram Cancer Center, Nashville, TN; and Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT.
Denise Portner, SteegeThomson Communications